Objective: Testing the efficacy and safety of estrogen plus progestin therapy for prevention of recurrent coronary heart disease (CHD) events in women

Conclusion: Based on the favorable pattern of CHD outcome in years 4 and 5 it may be appropriate for women ALREADY receiving this treatment to continue 

To read the complete study please click HERE

Deborah Grady, William Applegate, Trudy Bush, Curt Furberg, Betty Riggs, Stephen B. Hulley, Heart and Estrogen/progestin Replacement Study (HERS): Design, Methods, and Baseline Characteristics, Controlled Clinical Trials, Volume 19, Issue 4, 1998, Pages 314-335, ISSN 0197-2456, https://doi.org/10.1016/S0197-2456(98)00010-5